Background: The intrinsic catalytic dipeptidyl peptidase IV activity of the
T cell activation Ag CD26 is crucial for its costimulatory efficacy.
Methods:In this study, we investigated the immunomodulatory effect of CD26/
DPP IV,by targeting its catalytic moiety.
Results: Treated recipients showed a significant and rapid decrease in TCR,
CD3 and CD45 cellular expression kinetics on PBL and a reduction in IL-2 a
nd IFN-gamma intragraft mRNA expression. Enzymatic inhibition during sensit
ization abrogated accelerated rejection in > 50% of treated recipients.
Conclusion: These findings further support the hypothesis that DPP IV/CD26
is associated with allo-Ag mediated immune responses, indicating a graded b
ut central involvement in pathways of cellular and humoral immunity.